Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 4/2006

01-12-2006 | Article

Detection of HER-2/neu gene amplification in breast carcinomas using quantitative real-time PCR — A comparison with immunohistochemical and FISH results

Authors: Janina Kulka, Anna-Mária Tokés, Pál Kaposi-Novák, Nóra Udvarhelyi, Anikó Keller, Gábor Lotz, Zsuzsa Schaff

Published in: Pathology & Oncology Research | Issue 4/2006

Login to get access
Metadata
Title
Detection of HER-2/neu gene amplification in breast carcinomas using quantitative real-time PCR — A comparison with immunohistochemical and FISH results
Authors
Janina Kulka
Anna-Mária Tokés
Pál Kaposi-Novák
Nóra Udvarhelyi
Anikó Keller
Gábor Lotz
Zsuzsa Schaff
Publication date
01-12-2006
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 4/2006
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/BF02893412

Other articles of this Issue 4/2006

Pathology & Oncology Research 4/2006 Go to the issue

Article

Divergences in diagnosing nodular breast lesions of noncarcinomatous nature

Article

Clinical findings and HER-2/neu gene amplification status of breast carcinoma patients

Case Report

Asymmetric calf hypertrophy of neurogenic origin

Erratum

Human papilloma virus and p53 expression in bladder cancer in Egypt: Relationship to schistosomiasis and clinicopathological factors

Case Report

Subcutaneous metastasis of peritoneal mesothelioma diagnosed by Fine-Needle Aspiration

Case Report

Malignant pilomatricoma in the parietal area
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits